Incidence trends of conjunctival malignant melanoma in Canada.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 01 2019
revised: 01 04 2019
accepted: 07 04 2019
pubmed: 13 5 2019
medline: 29 7 2020
entrez: 13 5 2019
Statut: ppublish

Résumé

Melanoma is the most common primary malignancy of the eye in adults. While the epidemiology of uveal melanoma has recently been described in Canada, little is known about the epidemiology and geographic distribution of patients with conjunctival melanoma (CM) in Canada. We conducted a population-based study of CM incidence across all Canadian provinces and territories during 1992-2010 using two independent population-based registries. 190 patients were diagnosed with CM in Canada from 1992 to 2010. 55.3 % of these patients were men. The mean annual incidence rate of CM in Canada was 0.32 cases per million individuals (0.35 and 0.29 cases per million individuals for men and women, respectively). The incidence rates for Canadian provinces demonstrated that the eastern provinces of Nova Scotia and New Brunswick had higher age-adjusted incidence rates than the national average, with rates of 0.52 and 0.47 cases per million individuals per year, respectively. This analysis demonstrates novel variations in CM incidence rates between different Canadian provinces. These results taken together with the data reported from the USA confirm the North-to-South geographic gradient of increasing CM incidence. This research highlights that the epidemiology of CM in North America is comparable to that of cutaneous malignant melanoma in contrast to the trends for uveal melanoma distribution.

Sections du résumé

BACKGROUND
Melanoma is the most common primary malignancy of the eye in adults. While the epidemiology of uveal melanoma has recently been described in Canada, little is known about the epidemiology and geographic distribution of patients with conjunctival melanoma (CM) in Canada.
METHODS
We conducted a population-based study of CM incidence across all Canadian provinces and territories during 1992-2010 using two independent population-based registries.
RESULTS
190 patients were diagnosed with CM in Canada from 1992 to 2010. 55.3 % of these patients were men. The mean annual incidence rate of CM in Canada was 0.32 cases per million individuals (0.35 and 0.29 cases per million individuals for men and women, respectively). The incidence rates for Canadian provinces demonstrated that the eastern provinces of Nova Scotia and New Brunswick had higher age-adjusted incidence rates than the national average, with rates of 0.52 and 0.47 cases per million individuals per year, respectively.
CONCLUSIONS
This analysis demonstrates novel variations in CM incidence rates between different Canadian provinces. These results taken together with the data reported from the USA confirm the North-to-South geographic gradient of increasing CM incidence. This research highlights that the epidemiology of CM in North America is comparable to that of cutaneous malignant melanoma in contrast to the trends for uveal melanoma distribution.

Identifiants

pubmed: 31079055
pii: bjophthalmol-2019-313977
doi: 10.1136/bjophthalmol-2019-313977
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-25

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Feras M Ghazawi (FM)

Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.

Rami Darwich (R)

Medicine, McGill University, Montreal, Quebec, Canada.

Michelle Le (M)

Dermatology, McGill University Health Centre, Montreal, Quebec, Canada.
Dermatology, McGill University, Montreal, Quebec, Canada.

Abdulhadi Jfri (A)

Dermatology, McGill University Health Centre, Montreal, Quebec, Canada.
Dermatology, McGill University, Montreal, Quebec, Canada.

Elham Rahme (E)

Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada.

Julia Valdemarin Burnier (JV)

Cancer Research Program, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Denis Sasseville (D)

Dermatology, McGill University Health Centre, Montreal, Quebec, Canada.
Dermatology, McGill University, Montreal, Quebec, Canada.

Miguel N Burnier (MN)

Cancer Research Program, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Ivan V Litvinov (IV)

Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada ivan.litvinov@mcgill.ca.
Dermatology, McGill University, Montreal, Quebec, Canada.
Cancer Research Program, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH